Beyond Serendipity

We are entering the era of systems biology, where to truly understand a disease we must understand its causes from the molecular level to the organism level. The sheer number of biological molecules, and the complex nature of their interactions, has engendered a new method of biological experimentation, termed by Leroy Hood as "discovery science." Discovery science is technology-driven, and contrasted with hypothesis-driven science because it relies on making large-scale observations that are

Written byPaul Thomas
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

We are entering the era of systems biology, where to truly understand a disease we must understand its causes from the molecular level to the organism level. The sheer number of biological molecules, and the complex nature of their interactions, has engendered a new method of biological experimentation, termed by Leroy Hood as "discovery science."

Discovery science is technology-driven, and contrasted with hypothesis-driven science because it relies on making large-scale observations that are not necessarily directly testing a specific hypothesis. These observations can then generate hypotheses to be tested, or even confirm existing hypotheses. The most conspicuous recent example of discovery science is the sequencing of the human genome.

Use of the definite article in "the human genome" refers to a kind of Platonic ideal--in actuality, there are as many human genomes as there are humans, identical twins notwithstanding. This represents one of the next frontiers for discovery science. Already, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies